SOLX Titanium Sapphire Laser for Trabeculoplasty
Glaucoma, Glaucoma, Open Angle
About this trial
This is an interventional treatment trial for Glaucoma focused on measuring Glaucoma, Glaucoma, open angle, Intraocular Pressure, Trabeculoplasty, laser, laser, surgery
Eligibility Criteria
Inclusion Criteria:Clinical Diagnosis of Open Angle Glaucoma Patient is aged 18 years or older, with 2 sighted eyes. Eye to be treated have average IOP greater or equal to 22 mmHg, measured at 2 pretreatment visits. Eye to be treated either exhibits: poorly controlled open angle glaucoma and on maximal tolerated medical therapy OR poorly controlled open angle glaucoma and failed previous laser trabeculoplasty (180° available to treat if previous ALT; can treat over previous SLT) Exclusion Criteria: Patients are not eligible for enrollment if any of the following exclusion criteria are met: Eye to be treated has any of the following: evidence of glaucoma other than open-angle glaucoma; severe paracentral or generalized field defect; any ocular condition that precluded adequate visualization and treatment of the trabecular meshwork. prior glaucoma surgery other than laser trabeculoplasty or peripheral iridotomy. Patient has mental impairment such that he/she could not understand the protocol or is not in a position to provide written informed consent. Patient is pregnant. Patient might require other ocular surgery within the 6-month follow-up period. Patient has a medical history that suggested the potential for complications from TiSaLT. Having concurrent treatment with systemic steroids.
Sites / Locations
- North Bay Eye Associates
- International Eye Care
- Glaucoma Associates of New York
- Texan Eye Care
- Mann Eye Institute
- Credit Valley EyeCare
- Institut du Glaucome de Montréal
- Sourasky Medical Center
- Sheba Medical Center
- Hospital Clinico San Carlos de Madrid
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
1
2
Titanium sapphire laser treatment
Argon laser treatment